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The human high-affinity copper transporter (hCtr1) is a membrane protein that is predicted to have three transmembrane helices and two
methionine-rich metal binding motifs. As an oligomeric polytopic membrane protein, hCtr1 is a challenging system for experimental structure
determination. The results of an initial application of solution-state NMR methods to a truncated construct containing residues 45–190 in micelles
and site-directed mutagenesis of the two cysteine residues demonstrate that Cys-189 but not Cys-161 is essential for both dimer formation and
proper folding of the protein.
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Copper is an essential trace element in biology. Largely
because of its roles in redox chemistry, it is involved in a wide
variety of cellular functions including photosynthesis and res-
piration, free radical eradication, neurological development, and
iron homeostasis [1,2]. As is the case for many essential trace
metals, excess copper is toxic, and intracellular copper levels
are tightly regulated so that sufficient copper is absorbed and
excess copper is secreted. Menkes syndrome (copper deficien-
cy) and Wilson disease (copper toxicosis) demonstrate the me-
tabolic requirement for and toxicity of copper in humans; these
diseases are caused by mutations in the P-type ATPases, ATP7A
and ATP7B, respectively. Progress has been made toward un-
derstanding the mechanism of the intracellular copper transport
through the metallochaperones, in large part due to the structure
determinations of the key proteins [3–5]. In contrast, the
mechanism of copper translocation across cellular membranes
is largely unknown.
Copper transporters (CTR) are a family of proteins respon-
sible for cellular copper uptake. Genetic studies in the yeast⁎ Corresponding author.
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proteins involved in high-affinity copper uptake at the plasma
membrane of eukaryotic cells, yCTR1 and yCTR3 [6,7]. The
human high-affinity copper transporter (hCtr1) was subse-
quently identified by functional complementation studies of an
yCTR1 deletion mutant [8]. The 190-residue hCtr1 protein is
predicted to have three transmembrane helical segments and
two methionine-rich metal binding motifs. Several different
models of the oligomerization state of the protein have been
proposed, including a dimer [9], a trimer [10], and a dimer of
trimers [11]. A connection between the resistance to extracel-
lular copper and the resistance to cis-diamminedichloroplati-
num(II) (cisplatin), a platinum-based chemo-therapeutic agent,
has been observed [12–14]. The involvement of CTR1 in cis-
platin transport has also been demonstrated by showing the
effect of ctr1 deletion on cisplatin resistance as well as compe-
titive uptake between copper and cisplatin [15].
As an oligomeric polytopic membrane protein, hCtr1 is a
challenging system for experimental structure determination. In
order to simplify the problem somewhat and to focus on the
membrane-associated domain of the protein, we prepared a
truncated construct, hCtr1TM , which includes residues 45–190,
as indicated in Fig. 1. In this article we describe an initial
application of solution-state NMR methods to hCtr1TM in
Fig. 1. The amino acid sequence of hCTR1 arranged to suggest a plausible
structural arrangement. The two Cys residues mutated in this study are shown in
red. The two copper binding motifs are shown in green. The N-terminal region
was truncated at the position marked with the dashed line, leaving the sequence
for the construct hCTR1TM .
Table 1
Oligonucleotides used in the site-directed mutagenesis for hCTR1TM
R90CGC
forward
GGACTCAAGATAGCCCGCGAGAGCCTGCTGCG
R90CGC
reverse
CGCAGCAGGCTCTCGCGGGCTATCTTGAGTCC
C161S
forward
CCTACAACGGGTACCTCAGCATTGCAGTAGCAGCAGG
C161S
reverse
CCTGCTGCTACTGCAATGCTGAGGTACCCGTTGTAGG
C189S
forward
GGATATCACAGAGCATAGCCATCTCGAGCACCACC
C189S
reverse
GGTGGTGCTCGAGATGGCTATGCTCTGTGATATCC
Targeted mutation points are shown in bold. Primers are shown in the 5′ to 3′
direction.
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paration for the attachment of spin-labels for PRE (paramag-
netic relaxation enhancement) measurements [16–18] we found
that the protein was highly sensitive to the presence or absence
of the cysteine residue at position 189 but not the one at position
161 as monitored by two-dimensional HSQC (heteronuclear
single quantum correlation) NMR spectra and behavior on SDS
PAGE (sodium dodecyl sulfate polyacrylamide gel electropho-
resis). These results demonstrate that not only is Cys-189 in-
volved in the formation of stable dimers, but also is essential for
the correct folding of the protein.
2. Methods and materials
2.1. Cloning of wt-hCTR1TM, C161S-hCTR1TM, C189S-hCTR1TM, and
C161S/C189S-hCTR1TM
cDNA corresponding to amino acid residues 45–190 of hCtr1, hCtr1TM, was
PCR amplified from the DNA encoding full-length hCtr1 using the oligo-
nucleotides 5′-GGAATTCCATATGACCTTCTACTTTGG and 5′-CCGCTC-
GAGATGGCAATGCTCTGTG. The PCR products were digested with the
restriction enzymes NdeI and XhoI (New England Biolabs, Ipswich, MA), and
purified by agarose gel electrophoresis using the protocol supplied with a Gel
Extraction Kit (Qiagen, Valencia, CA). The DNA fragment was ligated into the
vector pET-31b(+) (EMD Biosciences, La Jolla, CA) which was cut by the same
restriction enzymes and purified. The ligation product was transformed into
DH5α competent cells (Invitrogen Corp., Carlsbad, CA) and the DNA sequence
was verified. A PCR test with the same oligonucleotide primers was performed
to confirm if the ligation product contains the target PCR product. Further
confirmation came from digesting with the restriction enzyme EcoRV to ensure
the restriction digest yields the fragments of correct sizes. The final recombinant
plasmid, pEThCTR1TM, codes for amino acid residues 45–190 of hCTR1 with
the amino acids LEHHHHHH attached at the C-terminus.A single rare codon for Escherichia coli was found within the gene for
hCtr1TM at the position encoding Arg-90 (CGA) that was optimized by changing
it to CGC using the standard site-directed mutagenesis protocol (QuikChange,
Stratagene, La Jolla, CA)with the primers listed in Table 1. Two cysteine residues
in the hCTR1TM polypeptide, Cys-161 and Cys-189, were changed to serine
residues following the standard site-directed mutagenesis protocol with the
primers listed in Table 1.
Four different hCTR1TM constructs were generated using the primers listed
in Table 1: wt-hCtr1TM, C161S-hCtr1TM, C189S-hCtr1TM, and C161S/C189S-
hCtr1TM. All mutations were performed using the Pfu polymerase-mediated
reaction on the full-length plasmids. The sequences of the constructs were
verified by sequencing the plasmid using T7 promoter as a primer.
2.2. Expression and Western blot analysis of hCTR1TM constructs
The recombinant plasmids were transformed into E. coli competent cells
C43(DE3) (Imaxio, France) and grown on LB agar plates containing 100 μg/mL
carbenicillin. A single colony was picked and inoculated in 5 mL LB media with
100 μg/mL carbenicillin at 37 °C, 260 rpm for 2 h. 500 μL of the culture was
transferred into 100 mL M9 minimal media containing 3% LB media and
incubated at 37 °C overnight, then 30 mL of the culture was transferred to 1 L
M9 minimal media containing 3% LB media. The target protein expression was
induced using 0.4 μM isopropyl-β-D-thiogalactoside (IPTG) when the OD600
reached a value of ∼0.6, followed by incubation for an additional 4 h at 37 °C.
The cells were harvested by centrifugation at 12,000×g for 45 min at 4 °C using
a Beckman Avanti J-20 XP centrifuge with a JLA-8.1 rotor. Isotope labeling was
achieved by utilizing 15N-ammonium sulfate (Cambridge Isotope Laboratories,
Inc., Andover, MA) as the sole nitrogen source in the growth media.
Western blot analysis was performed on whole cells using an antibody
directed against C-terminal amino acid residues of hCTR1 (Novus biologicals,
Inc., Littleton, CO) with the standard immunoblotting protocol. The samples
were loaded onto a 12% SDS-PAGE gel and electroblotted onto a polyvinyli-
dene difluoride (PVDF) transfer membrane by applying 30 V for 1 h. The
blotted membrane was blocked using TBS-Tween20 buffer (25 mMTris–Cl, pH
7.4, 150 mM NaCl, 0.05% Tween-20) containing 5% milk for 1 h and incubated
overnight with TBS-Tween20 buffer containing anti-C-terminal antibody di-
luted to 1:1000. The membrane was washed with TBS buffer three times for
10 min and incubated for 1 h with secondary ECL horseradish peroxidase
(HRP)-conjugated anti-rabbit antibody (GE Healthcare Bio-Sciences Corp.,
Piscataway, NJ) diluted to 1:1000. The bands were visualized using SIGMAfast
3,3-diaminobenzidine (DAB) tablets (Sigma-Aldrich, St. Louis, MO). InVision
His-tag In-gel Stain (Invitrogen Corp., Carlsbad, CA) was used to detect the
proteins with hexa-Histidine tag following the standard protocol.
2.3. Purification of hCtr1TM
Cells containing the expressed target proteins were resuspended in 20 mL of
lysis buffer (50 mM sodium phosphate, 1 M NaCl, 5 mM EDTA, pH 7.6) per
Fig. 2. (A) A schematic diagram of the plasmid pEThCTR1TM. The expression
of hCTR1TM was confirmed by (B) SDS-PAGE, (C) InVision His-tag In-gel
Stain, and (D) Western blot detected with anti-C-terminal hCTR1. Lanes marked
as “M” indicate the protein standards, with the standardized molecular weights
in kDa indicated next to the lanes. Samples containing the whole cells before the
induction were labeled “I−”, and 4 h after the induction, “I+”. The cells loaded
onto each lane were ‘normalized’ according to OD600 values.
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Science, Indianapolis, IN). The resuspended cells were lysed by sonicating on ice
for 4 min (5 s on, 5 s off) three times. Unlysed cells and inclusion body fractions
were removed by centrifugation at 6000×g for 30 min at 4 °C using a Beckman
Avanti J-20 XP centrifuge with a JA-25.50 rotor. The membrane fraction
containing the target protein was separated from the fraction containing soluble
proteins by centrifuging the supernatant at 90,000×g for 3 h at 4 °C using a
Beckman Optima L-100 XP Ultracentrifuge with a 45Ti rotor. The isolated
membrane fraction was then dissolved in 1%w/v dodecylphosphocholine (DPC,
Fos-Choline-12, Anatrace, Inc., Maumee, OH) in 20 mL of buffer A (50 mM
sodium phosphate, 1MNaCl, pH 7.6) per gramwet cells and incubated overnight
at 4 °C with gentle agitation. The extracted solution was centrifuged at 90,000×g
for 20 min at 4 °C to separate undissolved materials left in the membrane
fractions.
After the selective extraction, the supernatant containing the target protein
dissolved in DPC was incubated with Ni-NTA resin (Qiagen, Valencia, CA) pre-
equilibrated with buffer A, for 1 h at 4 °C with gentle agitation. The protein-DPC
micelle mixture bound to Ni-NTA resin was loaded onto an empty column, and
washed with N2 bed volumes of 0.2% w/v DPC solution containing 50 mM
sodium phosphate, 1 M NaCl, and 5 mM imidazole at pH 7.6. Nonspecifically
bound proteins were removed by washing with N2 bed volumes of buffer
containing 0.2% w/v DPC, 50 mM sodium phosphate, 1 M NaCl, and 30 mM
imidazole at pH 7.6. The target protein was eluted with buffer containing 0.2%
w/v DPC, 50 mM sodium phosphate, 1 M NaCl, and 300 mM imidazole.
2.4. NMR sample preparation and experiments
5 mM EDTA was added to the sample purified with the nickel affinity
chromatography, and the sample was dialyzed against water for ∼2 days in a
dialysis bag with a molecular weight cutoff of 1 kDa. The precipitated sample
was collected by centrifugation followed by lyophilization. The NMR sample
was made by directly adding a stock solution of 100 mMDPC to the lyophilized
protein powder. 10% D2O was added to the sample, and the pH was adjusted to
5.0.
Standard 15N,1H-HSQC experiments were performed on a Bruker DRX 600
spectrometer with a TXI-cryoprobe and on a Bruker AVANCE 800 spectrometer.
The data were processed with NMRPipe [32], and analyzed with SPARKY
(T. D. Goddard and D. G. Kneller, SPARKY 3, University of California, San
Francisco).
3. Results
3.1. Cloning, expression, and purification of hCtr1TM
Since hCtr1 consists of 190 amino acids with three putative
transmembrane domains and oligomerizes, the challenges for
NMR spectroscopy start with sample preparation. The polypep-
tides need to be over-expressed in E. coli for uniform isotopic
labeling, purified to a high degree, and reconstituted into lipid
environments that are conducive not only to proper folding and
oligomerization, but also for NMR experiments [19].
The plasmid pEThCtr1TM (Fig. 2A) was designed so that the
hCtr1 constructs could be expressed in E. coli with a hexa-
Histidine (His6) tag added at the C-terminus to facilitate
purification with immobilized metal affinity chromatography.
The target protein for the studies described in this article,
hCtr1TM, consists of residues 45–190 of the native full-length
hCtr1. As shown in Fig. 1, the 146-residue hCtr1TM is expected
to contain all three transmembrane domains and the metal-
binding motif located between TM2 and TM3, but not the
second metal-binding motif located in the N-terminal region.
The His6 tag was placed at the C-terminus to prevent non-
specific interactions that might occur if the tag was at theN-terminus of the protein. The pET-31b(+) (EMD Biosciences,
Inc., San Diego, CA) plasmid, originally developed to over-
express the target protein with the ketosteroid isomerase (KSI)
fusion protein, was used to design the plasmid pEThCtr1TM,
with the KSI-encoding region removed by the restriction en-
zymes NdeI and XhoI.
After transformation into several trial strains of bacteria and
optimization of growth conditions, C43(DE3) was found to give
the expression level suitable for preparation of the milligram
quantities required for NMR studies. C43(DE3) and C41(DE3)
are the mutant strains of E. coli strain BL21(DE3) known to
survive when the expressed proteins are toxic to the host [20].
Nonetheless, we found it essential to test the specific host–
plasmid combinations in order to obtain optimal expression
levels. Using identical growth and expression protocols, BL21
(DE3) cells did not survive (the solution becomes clear and
OD600 goes down) 2 h after the induction at 37 °C; in contrast,
C43(DE3) survive 5 h after the induction.
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Luria–Bertani (LB) broth, did not yield protein expression at a
detectable level, but when the growth was switched to M9
minimal media, the expression level went up. This is a fortunate
situation for NMR studies where minimal media is required for
introducing stable isotopes, in this case 15N into all nitrogen
sites. Transformation of the plasmid into competent E. coli cells
designed for overcoming the codon-bias problem, such as Ro-
setta 2 (DE3) (EMD Biosciences, Inc., San Diego, CA) yielded
a small increase in the expression level, and a single rare codon
was found at the position encoding Arg-90, which was changed
to a more ‘abundant’ codon CGC by standard site-directed
mutagenesis. Varying IPTG concentrations from 0.2 μM to
1 μM did not change the expression level significantly with the
optimum IPTG concentration about 0.4 μM, but adding thia-
mine did help increase the expression level although the BL21
strain is not vitamin B1 deficient. Also, addition of 3%–5% LB
media to the minimal media helped increase the expression level
as well as the growth rate. Various induction times were tested
to optimize the expression level, and a significant reduction in
OD600 was observed after 6 h of induction at 37 °C. Lowering
the incubation temperature following induction is known to
reduce the toxicity caused by the over-production of membrane
proteins and localize the target protein within the membrane,
thus increasing the final yield of the protein. For hCtrTM,
inducing at 25 °C for 12–16 h resulted in significantly higher
cell density than inducing at 37 °C for 5 h, however, it did not
increase the amount of purified protein per liter of culture.
Following these optimization steps, the expression of hCtr1TM
results in a clearly visible band on the SDS-PAGE at a position
corresponding to a molecular weight of around 15 kDa (Fig. 2B).
hCtr1TM has a calculated monomeric molecular weight of
17.4 kDa. The cell concentrations loaded in each of the lanes
in Fig. 2 were normalized according to the OD600, thus the SDS-
PAGE shows the relative levels of polypeptides in the samples.
Proteins with the exposed His6 tag were detected using InVision
His-tag In-gel Stain (Invitrogen, Corp., Carlsbad, CA). The
InVision His-tag In-gel Stain consists of a fluorescent dye con-
jugated to a nickel–nitrilotriacetic acid (NTA) complex and
allows the specific detection of proteins with a polyHis-tag when
exposed to the ultraviolet light, as shown in Fig. 2C. An im-
munoblot using the antibody raised against the C-terminal region
of hCtr1 shown in Fig. 2D indicates that the protein expressed
after the induction contains the same amino acid sequence as the
C-terminal region of hCtr1.
Harvested cells were resuspended in a standard lysis buffer
for E. coli containing sodium phosphate buffer, ethylenedia-
mine tetraacetate (EDTA), and NaCl. Added protease inhibitors
were essential to keep the protein intact. The pellet containing
inclusion bodies and any unlysed cells was separated from the
solution containing the soluble proteins and the membrane
proteins associated the lipid membranes by low speed centri-
fugation. A majority of the expressed hCtr1TM was found in the
solution according to SDS-PAGE, which may explain some of
the anomalous expression results. This is also in agreement with
previous reports about the subcellular localization of hCtr1
[10,21]. We made many attempts to isolate the target proteinfrom the soluble fraction by solubilizing the membrane proteins
using various detergents such as Triton X-100 and Empigen BB
followed by purification using the metal affinity chromatogra-
phy, but the purity and the yield were not sufficient for NMR
studies. The purity was increased when the total membrane
fraction was separated from the solution using high-speed cen-
trifugation, and dissolved in a high concentration of detergent.
When a solution of the mild detergent n-dodecyl-β-D-maltoside
(DDM) was used, extraction of hCtr1TM from the membrane
occurred, while a solution of n-octyl-β-D-glucopyranoside (OG)
was unable to solubilize the target protein.
Ni2+ affinity chromatography in the presence of 0.2% DDM
enabled purification of hCtr1TM after optimizing conditions
such as salt concentration, pH, detergent concentration, and
imidazole concentration. However, when the final sample was
collected and the 15N/1H-HSQC spectrum was obtained, the
presence of the detergent DDM had adverse effects on the
spectrum, and the low critical micelle concentration (CMC) of
DDM (∼0.2 mM) prevented complete removal using dialysis.
Dodecylphosphocholine (DPC) has been established as an ex-
cellent micelle system, and has been used in a number of NMR
studies of membrane proteins, including Pf1 coat protein [22],
diacylglycerol kinase [23], phospholamban [24], PagP [25] and
OmpA [26]. When 1% DPC solution was added to the mem-
brane fraction isolated by high speed ultracentrifugation and
incubated overnight at 4 °C, a majority of the hCtr1TM was
solubilized and ready to be loaded onto the Ni-NTA resin.
Nickel affinity chromatography was carried out in the presence
of 0.2% DPC and the binding of hCTR1TM to Ni-NTA (Qiagen,
Valencia, CA) resin was very effective even without the pre-
sence of reducing agent.
SDS-PAGE of a protein sample from the final step of
purification is shown in Fig. 3A. The apparent molecular weight
of about 28 kDa suggests that it is a dimer. When the strong
reducing agent DTTwas added to the sample, the major band on
SDS-PAGE was detected around 15 kDa corresponding to the
size of hCtr1TM in the monomeric state. The weak band at
around 28 kDa was also detected, and this is presumably a small
amount of residual dimer. This agrees with previous reports that
show that full-length hCtr1 migrates as a monomer and a dimer
in non-reducing SDS-PAGE [9,10,27]. These data indicate that
the oligomerization properties characteristic of the 190-residue
hCtr1 are preserved in the 146-residue hCtr1TM, missing the
N-terminal 44 residues. The samples loaded onto the SDS gel
were purified by nickel affinity chromatography with the
protein dissolved in 0.2% DPC, 50 mM sodium phosphate pH
7.6, 1 M NaCl and 300 mM imidazole, before the lithium
dodecyl sulfate (LDS) sample buffer (Invitrogen Corp., Carls-
bad, CA) was added. This suggests that protein fold is not
disrupted by the presence of DPC, which is a similar result to
that reported for the pentameric phospholamban [24].
Two-dimensional 15N/1HHSQCNMR spectra were obtained
from samples of uniformly 15N labeled hCtr1TM in DPC mi-
celles. The optimal sample conditions (Fig. 4A) were ∼1 mM
protein concentration and 100 mM DPC at pH 5.0. Following
nickel affinity chromatography the polypeptide was dialyzed for
2 days against water, and lyophilized to powder. The NMR
Fig. 3. (A) Benchmark protein standard (Invitrogen Corp., Carlsbad, CA), labeled “M”, was used as a molecular weight standard with the standardized molecular
weight values in kDa indicated next to the lane. Various hCTR1TM cysteine mutants were analyzed by (A) SDS-PAGE and (B) Western blot detected using C-terminal
hCTR1 antibody. The presence or absence of DTT was indicated as + or − on top of the figures. The grey ovals displayed to the right indicate the locations of the
plausible oligomeric states of hCTR1TM.
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solution directly to the powder. When a strong reducing agent,
such as DTT or tris(2-carboxyethyl)phosphine hydrochloride
(TCEP-HCl), was added to anNMR sample, the resolution of the
spectrum degraded significantly. Although highly reproducible,
this is exactly the opposite of the usual result where the addition
of DTT improves the spectral resolution by reducing the cysteine
sidechains and eliminating both disulfide linked oligomers and
any incorrectly cross-linked polypeptides.
Many different detergents were surveyed in order to find the
conditions where hCtr1TM would yield reproducibly well-re-
solved spectra in the presence of a reducing agent. The lipids
examined included 1-myristoyl-2-hydroxy-sn-glycero-3-[phos-
pho-RAC-(1-glycerol)] (LMPG), 1,2-dicaproyl-1-sn-glycero-3-
phosphocholine (DHPC), n-octyl-β-D-glucopyranoside (OG),
sodium dodecyl sulfate (SDS), and DDM (n-dodecyl-β-D-mal-
toside). Most of the tested detergents were not compatible with
hCtr1TM. Due to low solubility of the protein in LMPG, DHPC,
and OG, there were no detectable signals in the 15N/1H-HSQC
NMR spectra. DDM and SDS did solubilize the protein, but did
not yield spectra as well resolved as those obtained in DPC. In
the spectra in Fig. 4A and B, the number of distinct resonances
is approximately the same as the number of residues in the
protein. This kind of variation of spectral quality among
detergents is typical of many membrane proteins [28]. It is the
response to reducing agents that makes hCtr1TM atypical.
3.2. Mutation of cysteine residues and the effect on the
oligomerization
The preparation of mutant hCtr1TM polypeptides containing
only a single cysteine residue allowed us to examine the in-
fluence of the individual sulfhydryl groups on the properties ofthe protein in the presence of SDS (on gels) and DPC (in NMR
samples). The two cysteines in hCtr1TM, Cys-161 and Cys-189,
were mutated into serines. Since Cys-161 is located in the
middle of the third transmembrane helix, labeling this residue
with nitroxide spin label could potentially provide sufficient
distance information for obtaining the backbone structure of the
protein. Three mutants were generated to examine the effect of
cysteine substitutions: two single amino acid substitution mu-
tants, C161S and C189S, and a double substitution mutant,
C161S/C189S. All the mutants were generated by following
the simple site-directed mutagenesis protocol (www.stratagene.
com/manuals/200518.pdf), and were transformed into the same
C43(DE3) cell line. The same expression, purification, and
sample preparation protocols were applied to all of the protein
species. All of the proteins were expressed at high levels within
the membrane fractions. The SDS-PAGE of all four hCtr1TM
proteins in the presence and absence of reducing agents are
compared in Fig. 3.
Clearly, the presence of the reducing agent DTT affects the
oligomerization state of wild type and C161S. The intensities of
the bands corresponding to the monomeric state of hCtr1TM, as
indicated as single grey oval in the figure, increase when DTT
was added to the wild type or C161S proteins. However, the
intensities of the bands for C189S and C161S/C189S are not
affected by the presence of DTT. This result indicates that the
dimeric state of hCtr1TM is stabilized by Cys-189, which is
located at the end of C-terminus. Using an antibody directed
against the C-terminal residues of hCtr1, the bands corres-
ponding to the monomeric state of hCtr1TM were identified in
Fig. 3B. This antibody failed to detect the dimer bands in the
absence of DTT, which could be due to the presence of a
disulfide linkage preventing the access of the antibody or other
factors.
Fig. 4. 15N,1H-HSQC spectra of hCTR1TM cysteine mutants, (A) wild type, (B) C161S, (C) C189S, and (D) C161S/C189S. The proteins were solubilized in 100 mM
DPC, and the pH was adjusted to 5.0. All the spectra were acquired at 323 K.
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findings was reiterated in the NMR spectra of the proteins,
which are shown in Fig. 4. The spectra of proteins containing
Cys-189 are reasonably well resolved, at least for a polytopic
membrane protein in micelles, and those of proteins without
Cys-189 are of poor quality. Remarkably, the resolution of the
15N/1H-HSQC spectra is inversely correlated with what would
be expected from the oligomerization state of hCtr1TM under the
conditions of the SDS-PAGE. The reduced monomers give
poorly resolved spectra, and the larger dimers give well-re-
solved spectra. The 15N/1H-HSQC spectra of the proteins miss-
ing Cys-189, C189S and the double mutant C161S/C189S, are
indistinguishable from those obtained from samples of wild
type hCtr1TM in the presence of DTT, and exhibit the cha-
racteristics typical of those from partially or completely un-
folded proteins, e.g. intense, highly overlapped signals with
very limited 1H chemical shift dispersion. This suggests thatreplacement of the cysteine residue at position 189 by serine
interferes with the oligomerization and folding of hCtr1TM. The
intermolecular disulfide bond formation was not reversible in
this case: once DTTwas added to the wild type hCtr1TM, raising
pH, adding hydrogen peroxide, adding a thiol-specific oxidizing
agent N,N,N,N-Tetramethylazodicarboxamide (diamide) and/or
re-purifying in the absence of DTT did not recover the spectral
quality.
4. Discussion
In the course of developing and optimizing samples for
NMR structural studies of the membrane protein hCtr1, we
discovered the crucial roles of Cys-189 in both oligomerization
and folding of the protein. This finding is in partial agreement
with previous studies that showed cysteine residues are respon-
sible for the stable oligomerization of hCtr1, as detected from
Fig. 5. A model of hCTR1 oligomerization consistent with the experimental
results in Figs. 3 and 4. (A) The possible dimeric arrangement of hCTR1, with
the dotted line representing the intermolecular disulfide bond between Cys-189
residues that seems to be necessary for the correct folding. The third
transmembrane domain helix was arranged to be located inside of the core as
suggested by previous report [11]. (B) Top view of hypothetical ‘trimer of dimer’
arrangement of hCTR1.
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membrane fraction [29]. However, the studies of Eisses and
Kaplan suggest that both of the cysteine residues are responsible
for the oligomerization and they showed a synergistic effect on
the copper transport. In contrast, the result reported here sug-
gests that Cys-189 is the only cysteine responsible for formation
of stable dimers. Other studies suggested that the oligomeriza-
tion of hCtr1 is stabilized by the Gly-X-X-X-Gly (GG4) motif
in the third transmembrane domain through helix packing [30],
and later, the same group reported a 6-Å resolution projection
structure of hCtr1 using electron microscopy, supporting the
importance of the third transmembrane domain for multime-
rization and helix packing and the trimeric arrangement [11] that
was initially suggested by the Thiele group using crosslinking
experiments [10]. However, the trimeric arrangement cannot be
explained by the formation of intermolecular disulfide bonds if,
as we find, only one of the two cysteine residues, is involved in
oligomerization. The Unger group also noticed the disulfide-
dependent profile during the purification using gel filtration
chromatography.
We suggest a model in Fig. 5 that reconciles many of the
new and earlier findings. This model has the individual
polypeptides linked as covalent dimers through their Cys-189
residues. Unger and coworkers suggest that the GG4 motif
within the third transmembrane domain stabilizes helixpacking [30] and that the third transmembrane domain may
be located on the inside of the ‘pore’ based on the projection
density map from the electron microscopy [31]. The locations
of the first and second transmembrane domains are currently
unknown, although the N-terminal extracellular domain has
been reported to interact with itself [9]. This self-association
between N-terminal extracellular domains suggests the hypo-
thetical model shown in Fig. 5B, where the top view of the
‘trimer of dimer’ model is depicted based on the previously
reported projection density map [11]. The circles with the same
color represent the transmembrane helices within the dimer
assembled through the disulfide bond as shown in Fig. 5A, and
different colors represent different subunits of the dimers. The
model shown here assumes that the third transmembrane
domains are located on the inside of the ‘pore’, and the trimeric
arrangement comes from the interactions between the N-
terminal extracellular domains, which is excluded in the
current study. Note that this model is based on the assumption
that the dimerization occurs first through the intermolecular
disulfide bond between the Cys-189 residues. It is possible that
the other residues, such as the GG4 motif, contribute to the
oligomerization process by assisting the helix packing.
However, the current study shows that residue Cys-189 plays
a critical role in the oligomerization and folding process, and it
is impossible to explain the oligomerization through the
intermolecular disulfide bonds with the trimer model that has
been suggested previously.
In summary, this article describes the cloning, expression and
purification of the transmembrane domain of hCtr1, hCtr1TM,
presents initial NMR spectra of hCtr1TM, and identifies residue
Cys-189 as crucial for oligomerization and folding of hCtr1TM
through the formation of intermolecular disulfide bonds. By
integrating these results with previous findings of other groups
we develop a plausible model for the organization of hCtr1 in
membrane environments that can be used as the basis for plan-
ning future structural and mechanistic studies.
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